GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 3,621 | 3,665 | 5,778 | 7,023 | 3,014 |
| Operating Income | -3,621 | -3,665 | -5,778 | -7,023 | -3,014 |
| Interest Expense | 1 | 212 | 0 | 0 | 0 |
| Other Income | 1,630 | 3,650 | 194 | 142 | 35 |
| Pre-tax Income | -1,992 | -227 | -5,584 | -6,881 | -2,979 |
| Net Income Continuous | -1,992 | -227 | -5,584 | -6,881 | -2,979 |
| Net Income | $-1,992 | $-227 | $-5,584 | $-6,881 | $-2,979 |
| EPS Basic Total Ops | -1.49 | -0.21 | -4.95 | -6.61 | -3.00 |
| EPS Basic Continuous Ops | -1.49 | -0.21 | -5.19 | -6.58 | -2.86 |
| EPS Diluted Total Ops | -1.49 | -0.21 | -4.95 | -6.61 | -3.00 |
| EPS Diluted Continuous Ops | -1.49 | -0.21 | -5.19 | -6.58 | -2.86 |
| EBITDA(a) | $-3,621 | $-3,665 | $-5,778 | $-7,023 | $-3,014 |